Advanced search
Publication Cover
Vascular Health and Risk Management Volume 4, 2008 - Issue 5
Submit an article Journal homepage
59
Views
10
CrossRef citations to date
0
Altmetric
Review

Optimizing endothelin receptor antagonist use in the management of pulmonary arterial hypertension

M Kathryn Steiner1 Pulmonary Critical Care Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA
&
Ioana R Preston2 Pulmonary Critical Care and Sleep Division, Department of Medicine, Tufts Medical Center, Boston, MA, USACorrespondence[email protected]
Pages 943-952 | Published online: 10 Oct 2008

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Peter Norman. (2014) Pulmonary arterial hypertension: a rare disease that encourages the development of multiple treatments. Expert Opinion on Orphan Drugs 2:11, pages 1137-1145.
Read now

Articles from other publishers (9)

Chibueze A. Ihunnah, Samit Ghosh, Scott Hahn, Adam C. Straub & Solomon F. Ofori-Acquah. (2022) Nrf2 Activation With CDDO-Methyl Promotes Beneficial and Deleterious Clinical Effects in Transgenic Mice With Sickle Cell Anemia. Frontiers in Pharmacology 13.
Crossref
Qinhua Zhao, Na Guo, Jun Chen, Daniel Parks & Zhuang Tian. (2021) Comparative assessment of efficacy and safety of ambrisentan and bosentan in patients with pulmonary arterial hypertension: A meta‐analysis. Journal of Clinical Pharmacy and Therapeutics 47:2, pages 146-156.
Crossref
Ailing Li, Zhongkai Zhu, Yangke He, Qian Dong, Dianyong Tang, Zhongzhu Chen & Wei Huang. (2020) DDCI‐01, a novel long acting phospdiesterase‐5 inhibitor, attenuated monocrotaline‐induced pulmonary hypertension in rats. Pulmonary Circulation 10:4, pages 1-10.
Crossref
Susan Lepri, Laura Goracci, Aurora Valeri & Gabriele Cruciani. (2016) Metabolism study and biological evaluation of bosentan derivatives. European Journal of Medicinal Chemistry 121, pages 658-670.
Crossref
Jasmin Raja & Christopher Paul Denton. (2015) Cytokines in the immunopathology of systemic sclerosis. Seminars in Immunopathology 37:5, pages 543-557.
Crossref
Gan Hui-li. (2011) The Management of Acute Pulmonary Arterial Hypertension. Cardiovascular Therapeutics 29:3, pages 153-175.
Crossref
Clotilde Dechanet, Aurélie Fort, Elisabet Barbero-Camps, Hervé Dechaud, Sylvain Richard & Anne Virsolvy. (2011) Endothelin-Dependent Vasoconstriction in Human Uterine Artery: Application to Preeclampsia. PLoS ONE 6:1, pages e16540.
Crossref
N. Giordano, L. Puccetti, P. Papakostas, N. Di Pietra, F. Bruni, A.L. Pasqui, M. Acampa, V. Bocchi, V. Donati, M. Voglino, A. Fioravanti, A. Montella, A. Auteri, R. Nuti & M. Pastorelli. (2010) Bosentan Treatment for Raynaud's Phenomenon and Skin Fibrosis in Patients with Systemic Sclerosis and Pulmonary Arterial Hypertension: An Open-Label, Observational, Retrospective Study. International Journal of Immunopathology and Pharmacology 23:4, pages 1185-1193.
Crossref
Shahzad G. Raja. (2010) REVIEW: Endothelin Receptor Antagonists for Pulmonary Arterial Hypertension: An Overview. Cardiovascular Therapeutics 28:5, pages e65-e71.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.